docetaxel anhydrous has been researched along with cycloheximide in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (cycloheximide) | Trials (cycloheximide) | Recent Studies (post-2010) (cycloheximide) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 19,109 | 6 | 861 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | cycloheximide (IC50) |
|---|---|---|---|
| COUP transcription factor 2 isoform a | Homo sapiens (human) | 1.315 | |
| Glucose transporter | Leishmania mexicana | 0.242 | |
| Hexose transporter 1 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.31 | |
| Solute carrier family 2, facilitated glucose transporter member 1 | Homo sapiens (human) | 0.228 | |
| Eukaryotic initiation factor 4A-I | Homo sapiens (human) | 0.139 | |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | 3.6 | |
| Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 0.036 | |
| Endothelial PAS domain-containing protein 1 | Homo sapiens (human) | 0.036 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, SR; Guo, B; Hembruff, SL; Kalatskaya, I; Lanner, C; Parissenti, AM; Reed, K; Sprowl, JA; Stein, L; Tam, A | 1 |
1 other study(ies) available for docetaxel anhydrous and cycloheximide
| Article | Year |
|---|---|
Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Survival; Cycloheximide; Docetaxel; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; MCF-7 Cells; NF-kappa B; Ovarian Neoplasms; Paclitaxel; Protein Synthesis Inhibitors; Proteolysis; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Signal Transduction; Taxoids; Transcriptional Activation; Tumor Necrosis Factor-alpha | 2012 |